Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2873) 2873
Newsletter (13) 13
Book Chapter (7) 7
Magazine Article (6) 6
Conference Proceeding (4) 4
Newspaper Article (3) 3
Book / eBook (1) 1
Book Review (1) 1
Publication (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2276) 2276
amlodipine - therapeutic use (1861) 1861
science & technology (1855) 1855
life sciences & biomedicine (1822) 1822
male (1664) 1664
hypertension - drug therapy (1582) 1582
female (1495) 1495
middle aged (1372) 1372
amlodipine (1251) 1251
antihypertensive agents - therapeutic use (1185) 1185
aged (1055) 1055
calcium channel blockers - therapeutic use (983) 983
hypertension (975) 975
blood pressure - drug effects (895) 895
adult (820) 820
cardiovascular system & cardiology (800) 800
biological and medical sciences (741) 741
medical sciences (732) 732
treatment outcome (665) 665
pharmacology & pharmacy (634) 634
drug therapy, combination (593) 593
amlodipine - administration & dosage (570) 570
hypertension - physiopathology (555) 555
amlodipine - adverse effects (538) 538
pharmacology. drug treatments (535) 535
double-blind method (513) 513
peripheral vascular disease (494) 494
amlodipine - pharmacology (439) 439
cardiovascular system (407) 407
antihypertensive agents - administration & dosage (383) 383
blood pressure (361) 361
tetrazoles - therapeutic use (356) 356
cardiac & cardiovascular systems (347) 347
antihypertensive agents - adverse effects (343) 343
animals (341) 341
hypertension - complications (340) 340
drug combinations (335) 335
antihypertensive agents (333) 333
drug therapy (320) 320
angiotensin-converting enzyme inhibitors - therapeutic use (281) 281
calcium channel blockers - adverse effects (274) 274
prospective studies (270) 270
abridged index medicus (267) 267
calcium channel blockers - pharmacology (256) 256
calcium channel blockers - administration & dosage (255) 255
valsartan (238) 238
risk factors (235) 235
time factors (233) 233
cardiology. vascular system (231) 231
general & internal medicine (215) 215
medicine, general & internal (211) 211
antihypertensive agents - pharmacology (210) 210
hydrochlorothiazide - therapeutic use (208) 208
angiotensin ii type 1 receptor blockers - therapeutic use (205) 205
blood and lymphatic vessels (199) 199
dosage and administration (194) 194
dose-response relationship, drug (188) 188
calcium channel blockers (184) 184
aged, 80 and over (183) 183
arterial hypertension. arterial hypotension (183) 183
valine - analogs & derivatives (182) 182
heart rate - drug effects (174) 174
research (174) 174
medicine & public health (169) 169
blood pressure monitoring, ambulatory (161) 161
nifedipine - therapeutic use (161) 161
rats (159) 159
tetrazoles - administration & dosage (155) 155
care and treatment (153) 153
follow-up studies (151) 151
internal medicine (149) 149
valine - therapeutic use (149) 149
randomized controlled trials as topic (148) 148
adolescent (147) 147
calcium channel blocker (140) 140
analysis (139) 139
clinical trials (134) 134
benzimidazoles - therapeutic use (133) 133
cross-over studies (132) 132
tetrazoles - adverse effects (132) 132
diuretics (131) 131
hypertension - blood (130) 130
cardiology (129) 129
diuretics - therapeutic use (126) 126
pharmacology/toxicology (124) 124
blood pressure - physiology (122) 122
antihypertensive drugs (119) 119
amlodipine - pharmacokinetics (116) 116
hydrochlorothiazide - administration & dosage (114) 114
cardiovascular disease (113) 113
health aspects (110) 110
losartan - therapeutic use (109) 109
cardiovascular diseases - prevention & control (108) 108
enalapril - therapeutic use (108) 108
hydrochlorothiazide (108) 108
lisinopril - therapeutic use (108) 108
medicine, research & experimental (107) 107
research & experimental medicine (106) 106
angina pectoris - drug therapy (105) 105
clinical trials as topic (103) 103
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2735) 2735
Russian (68) 68
German (57) 57
Japanese (36) 36
Spanish (19) 19
French (18) 18
Chinese (17) 17
Italian (12) 12
Hungarian (10) 10
Polish (8) 8
Portuguese (7) 7
Ukrainian (6) 6
Czech (3) 3
Norwegian (3) 3
Danish (2) 2
Dutch (2) 2
Swedish (2) 2
Bosnian (1) 1
Croatian (1) 1
Hebrew (1) 1
Romanian (1) 1
Serbian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Effect of PCI on Quality of Life in Patients with Stable Coronary Disease
by Weintraub, William S and Spertus, John A and Kolm, Paul and Maron, David J and Zhang, Zefeng and Zhang, Wei and Jurkovitz, Claudine and Hartigan, Pamela M and Lewis, Cheryl and Veledar, Emir and Bowen, Jim and Dunbar, Sandra B and Deaton, Christi and Kaufman, Stanley and O'Rourke, Robert A and Goeree, Ron and Barnett, Paul G and Teo, Koon K and Boden, William E and COURAGE Trial Res Grp and COURAGE Trial Research Group
The New England journal of medicine, ISSN 0028-4793, 08/2008, Volume 359, Issue 7, pp. 677 - 687
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Heart | Biological and medical sciences | General aspects | Medical sciences | Coronary heart disease | Ticlopidine - therapeutic use | Vasodilator Agents - therapeutic use | Humans | Middle Aged | Calcium Channel Blockers - therapeutic use | Male | Angina Pectoris - etiology | Angina Pectoris - psychology | Angioplasty, Balloon, Coronary | Patient Satisfaction | Coronary Disease - complications | Female | Surveys and Questionnaires | Aspirin - therapeutic use | Isosorbide Dinitrate - therapeutic use | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Stents | Adrenergic beta-Antagonists - therapeutic use | Angina Pectoris - drug therapy | Metoprolol - therapeutic use | Combined Modality Therapy | Angina Pectoris - therapy | Ticlopidine - analogs & derivatives | Amlodipine - therapeutic use | Cross-Over Studies | Coronary Disease - therapy | Quality of Life | Health Status | Transluminal angioplasty | Care and treatment | Health aspects | Unstable angina | Risk factors | Medical research | Cardiovascular disease | Heart attacks | Angina pectoris | Coronary vessels | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Aging does not impact drug--drug interaction magnitudes with antiretrovirals
by Stader, Felix and Decosterd, Laurent and Stoeckle, Marcel and Cavassini, Matthias and Battegay, Manuel and Saldanha, Susana Alves and Marzolini, Catia and Courlet, Perrine and Swiss Hiv Cohort Study and and the Swiss HIV Cohort Study
AIDS (London), ISSN 0269-9370, 05/2020, Volume 34, Issue 6, pp. 949 - 952
Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Virology | Rosuvastatin Calcium - therapeutic use | Cardiovascular Diseases - drug therapy | HIV Infections - epidemiology | Humans | Middle Aged | Rosuvastatin Calcium - adverse effects | Male | Drug Interactions | Aged, 80 and over | Aging | Cardiovascular Diseases - epidemiology | Female | Anti-Retroviral Agents - therapeutic use | Atorvastatin - adverse effects | Atorvastatin - therapeutic use | Amlodipine - adverse effects | Treatment Outcome | Piperazines - therapeutic use | Piperazines - adverse effects | Amlodipine - therapeutic use | Antiretroviral Therapy, Highly Active | Oxazines - adverse effects | Cardiovascular Agents - therapeutic use | Oxazines - therapeutic use | Heterocyclic Compounds, 3-Ring - adverse effects | Heterocyclic Compounds, 3-Ring - therapeutic use | HIV Infections - drug therapy | Aged | Darunavir - adverse effects | Pyridones - therapeutic use | Cardiovascular Agents - adverse effects | Darunavir - therapeutic use | Pyridones - adverse effects | Index Medicus | AIDS/HIV
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Stenting and Medical Therapy for Atherosclerotic Renal-Artery Stenosis
by Cooper, Christopher J and Murphy, Timothy P and Cutlip, Donald E and Jamerson, Kenneth and Henrich, William and Reid, Diane M and Cohen, David J and Matsumoto, Alan H and Steffes, Michael and Jaff, Michael R and Prince, Martin R and Lewis, Eldrin F and Tuttle, Katherine R and Shapiro, Joseph I and Rundback, John H and Massaro, Joseph M and D'Agostino, Ralph B and Dworkin, Lance D and Coral Investigators and CORAL Investigators
The New England journal of medicine, ISSN 0028-4793, 01/2014, Volume 370, Issue 1, pp. 13 - 22
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | General aspects | Renovascular diseases | Atherosclerosis (general aspects, experimental research) | Nephropathies. Renovascular diseases. Renal failure | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Blood and lymphatic vessels | Follow-Up Studies | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Heptanoic Acids - therapeutic use | Humans | Middle Aged | Hypertension - drug therapy | Male | Renal Insufficiency, Chronic - complications | Renal Artery | Treatment Failure | Cardiovascular Diseases - mortality | Female | Angioplasty, Balloon | Pyrroles - therapeutic use | Stents | Cardiovascular Diseases - etiology | Renal Artery Obstruction - drug therapy | Kaplan-Meier Estimate | Combined Modality Therapy | Antihypertensive Agents - therapeutic use | Amlodipine - therapeutic use | Renal Artery Obstruction - complications | Anticholesteremic Agents - therapeutic use | Hypertension - complications | Aged | Renal Artery Obstruction - therapy | Drug Combinations | Prevention | Evaluation | Care and treatment | Usage | Atherosclerosis | Therapeutics | Stent (Surgery) | Homeopathy | Materia medica and therapeutics | Hypertension | Myocardial infarction | Cerebral infarction | Stroke | Kidneys | Renal artery | Antihypertensives | Medical treatment | Clinical trials | Stenosis | Cardiovascular disease | Congestive heart failure | Renal insufficiency | Arteriosclerosis | Implants | Renal failure | Blood pressure | Kidney diseases | Geriatrics | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients
by Jamerson, Kenneth and Weber, Michael A and Bakris, George L and Dahlöf, Björn and Pitt, Bertram and Shi, Victor and Hester, Allen and Gupte, Jitendra and Gatlin, Marjorie and Velazquez, Eric J and ACCOMPLISH Trial Investigators
The New England journal of medicine, ISSN 0028-4793, 12/2008, Volume 359, Issue 23, pp. 2417 - 2428
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Biological and medical sciences | General aspects | Arterial hypertension. Arterial hypotension | Medical sciences | Blood and lymphatic vessels | Benzazepines - adverse effects | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Calcium Channel Blockers - therapeutic use | Hypertension - drug therapy | Male | Risk | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Female | Blood Pressure - drug effects | Drug Therapy, Combination | Hydrochlorothiazide - adverse effects | Double-Blind Method | Kaplan-Meier Estimate | Amlodipine - adverse effects | Antihypertensive Agents - therapeutic use | Amlodipine - therapeutic use | Antihypertensive Agents - adverse effects | Benzazepines - therapeutic use | Diuretics - therapeutic use | Aged | Hydrochlorothiazide - therapeutic use | Hypertension | Prevention | Care and treatment | Usage | Benazepril | Cardiovascular diseases | Health aspects | Comparative studies | Clinical trials | Pharmacology | Calcium | ACE inhibitors | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Tako-tsubo cardiomyopathy observed in a patient with sepsis and transient hyperthyroidism
by Sarullo, Filippo M and Americo, Luigi and Accardo, Salvatore and Cicero, Sergio and Schicchi, Rossella and Schirò, Maria and Castello, Antonio
Monaldi archives for chest disease, ISSN 1122-0643, 03/2009, Volume 72, Issue 1, pp. 33 - 36
Sepsis | Ventricular function | Tako-tsubo cardiomyopathy | Transient hyperthyroidism | Glucocorticoids - therapeutic use | Echocardiography | Hyperthyroidism - diagnosis | Humans | Middle Aged | Propranolol - therapeutic use | Antithyroid Agents - therapeutic use | Ofloxacin - therapeutic use | Hyperthyroidism - drug therapy | Sepsis - complications | Takotsubo Cardiomyopathy - diagnosis | Antihypertensive Agents - therapeutic use | Takotsubo Cardiomyopathy - complications | Amlodipine - therapeutic use | Anti-Bacterial Agents - therapeutic use | Sepsis - drug therapy | Methimazole - therapeutic use | Electrocardiography | Hyperthyroidism - complications | Female | Aspirin - therapeutic use | Ramipril - therapeutic use | Platelet Aggregation Inhibitors - therapeutic use | Prednisone - therapeutic use | Index Medicus | transient hyperthyroidism | sepsis | ventricular function
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Greater efficacy of aldosterone blockade and diuretic reinforcement vs. dual renin–angiotensin blockade for left ventricular mass regression in patients with resistant hypertension
by Azizi, Michel and Perdrix, Ludivine and Bobrie, Guillaume and Frank, Michael and Chatellier, Gilles and Ménard, Joël and Plouin, Pierre-François
Journal of hypertension, ISSN 0263-6352, 10/2014, Volume 32, Issue 10, pp. 2038 - 2044
Peripheral Vascular Disease | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Bisoprolol - therapeutic use | Humans | Middle Aged | Hypertension - drug therapy | Male | Biphenyl Compounds - therapeutic use | Hypertension - etiology | Young Adult | Furosemide - therapeutic use | Aldosterone - metabolism | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Amiloride - therapeutic use | Adult | Female | Blood Pressure - drug effects | Hypertrophy, Left Ventricular - drug therapy | Ramipril - therapeutic use | Drug Therapy, Combination | Spironolactone - therapeutic use | Blood Pressure Determination | Hypertrophy, Left Ventricular - etiology | Renin - blood | Amlodipine - therapeutic use | Mineralocorticoid Receptor Antagonists - therapeutic use | Adolescent | Diuretics - therapeutic use | Renin-Angiotensin System - drug effects | Tetrazoles - therapeutic use | Aged | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Effects of Ranolazine with Atenolol, Amlodipine, or Diltiazem on Exercise Tolerance and Angina Frequency in Patients with Severe Chronic Angina: A Randomized Controlled Trial
by Chaitman, Bernard R and Pepine, Carl J and Parker, John O and Skopal, Jaroslav and Chumakova, Galina and Kuch, Jerzy and Wang, Whedy and Skettino, Sandra L and Wolff, Andrew A and CARISA Investigators and Combination Assessment of Ranolazine In Stable Angina (CARISA) Investigators
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 01/2004, Volume 291, Issue 3, pp. 309 - 316
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Angina Pectoris - physiopathology | Physical Exertion - physiology | Humans | Middle Aged | Calcium Channel Blockers - therapeutic use | Male | Physical Exertion - drug effects | Myocardial Ischemia | Ranolazine | Exercise Test | Electrocardiography | Female | Drug Therapy, Combination | Acetanilides | Adrenergic beta-Antagonists - therapeutic use | Double-Blind Method | Nitroglycerin - therapeutic use | Angina Pectoris - drug therapy | Piperazines - therapeutic use | Amlodipine - therapeutic use | Cardiovascular Agents - therapeutic use | Atenolol - therapeutic use | Diltiazem - therapeutic use | Survival Analysis | Aged | Hemodynamics | Chronic Disease | Clinical trials | Angina pectoris | Drug testing | Medical treatment
Journal Article
Details down arrow
8. Full Text Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial
by Julius, Stevo and Kjeldsen, Sverre E and Weber, Michael and Brunner, Hans R and Ekman, Steffan and Hansson, Lennart and Hua, Tsushung and Laragh, John and McInnes, Gordon T and Mitchell, Lada and Plat, Francis and Schork, Anthony and Smith, Beverly and Zanchetti, Alberto and for the VALUE trial group and VALUE Trial Grp and VALUE trial group
The Lancet (British edition), ISSN 0140-6736, 06/2004, Volume 363, Issue 9426, pp. 2022 - 2031
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Calcium Channel Blockers - adverse effects | Valsartan | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Calcium Channel Blockers - therapeutic use | Hypertension - drug therapy | Male | Sodium Chloride Symporter Inhibitors - therapeutic use | Angiotensin II Type 1 Receptor Blockers | Endpoint Determination | Diuretics | Female | Blood Pressure - drug effects | Double-Blind Method | Risk Factors | Valine - analogs & derivatives | Amlodipine - adverse effects | Treatment Outcome | Antihypertensive Agents - therapeutic use | Hypertension - physiopathology | Amlodipine - therapeutic use | Antihypertensive Agents - adverse effects | Tetrazoles - therapeutic use | Valine - therapeutic use | Aged | Tetrazoles - adverse effects | Valine - adverse effects | Hydrochlorothiazide - therapeutic use | Hypertension | Medical research | Side effects | Drug therapy | Drugs | Heart attacks | Heart surgery | Angioplasty | Antihypertensives | Risk | Cardiovascular disease | Evidence-based medicine | Blood | Randomization | Measurement techniques | Blood pressure | Heart diseases | Age | Heart failure | Edema | Stroke | Mortality | Medical treatment | Health risks | Angina pectoris | Patients | Coronary artery disease | Morbidity | Hypotheses | Coronary vessels | Diabetes | Cardiovascular diseases | Health risk assessment | Mercury | ACE inhibitors | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Baseline Heart Rate, Antihypertensive Treatment, and Prevention of Cardiovascular Outcomes in ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial)
by Poulter, Neil R and Dobson, Joanna E and Sever, Peter S and Dahlöf, Björn and Wedel, Hans and Campbell, Norm R.C and ASCOT Investigators
Journal of the American College of Cardiology, ISSN 0735-1097, 09/2009, Volume 54, Issue 13, pp. 1154 - 1161
beta-blockers | heart rate | cardiovascular risk | hypertension | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Heart Rate | Europe | Humans | Middle Aged | Proportional Hazards Models | Coronary Disease - epidemiology | Coronary Disease - physiopathology | Hypertension - drug therapy | Male | Treatment Outcome | Antihypertensive Agents - therapeutic use | Bendroflumethiazide - therapeutic use | Hypertension - physiopathology | Amlodipine - therapeutic use | Coronary Disease - prevention & control | Atenolol - therapeutic use | Female | Aged | Perindopril - therapeutic use | Blood pressure | Heart attacks | Drug therapy | Cholesterol
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Successful re-administration of Pazopanib in a patient with metastatic renal cell carcinoma and a history of Pazopanib-induced nephrotic syndrome: A case report
by Jeon, So-Yeon and Lee, Na-Ri and Yim, Chang-Yeol
BMC nephrology, ISSN 1471-2369, 01/2019, Volume 20, Issue 1, pp. 1 - 1
Metastatic renal cell carcinoma | Nephrotic syndrome | Pazopanib | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Lung Neoplasms - drug therapy | Humans | Carcinoma, Renal Cell - surgery | Hypertension - drug therapy | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Pancreaticoduodenectomy | Pneumonectomy | Protein Kinase Inhibitors - adverse effects | Dihydropyridines - adverse effects | Pancreatic Neoplasms - drug therapy | Angiogenesis Inhibitors - administration & dosage | Pancreatic Neoplasms - secondary | Lung Neoplasms - secondary | Antineoplastic Agents - adverse effects | Angiogenesis Inhibitors - therapeutic use | Everolimus - therapeutic use | Carcinoma, Renal Cell - drug therapy | Nephrotic Syndrome - chemically induced | Angiogenesis Inhibitors - adverse effects | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Pyrimidines - administration & dosage | Pancreatic Neoplasms - surgery | Nivolumab - therapeutic use | Combined Modality Therapy | Antihypertensive Agents - therapeutic use | Amlodipine - therapeutic use | Diabetic Nephropathies - complications | Dihydropyridines - therapeutic use | Edema - etiology | Protein Kinase Inhibitors - administration & dosage | Sulfonamides - therapeutic use | Sunitinib - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Carcinoma, Renal Cell - secondary | Kidney Failure, Chronic - complications | Pyrimidines - adverse effects | Hypertension - complications | Sulfonamides - adverse effects | Lung Neoplasms - surgery | Aged | Drug Substitution | Sulfonamides - administration & dosage | Antimitotic agents | Care and treatment | Albumin | B cells | Carcinoma, Renal cell | Metastasis | Antineoplastic agents | Health aspects | Cancer | Urine | Hypertension | Edema | Biomedical research | Family medical history | Patients | Cholesterol | Metastases | Proteins | Biopsy | Renal cell carcinoma | Kidney cancer | Antitumor activity | Blood pressure | Clinical medicine | Vascular endothelial growth factor | Drug dosages | Research centers | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights